[HTML] mdpi.com

[HTML][HTML] MicroRNAs as indicators of malignancy in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions

C Prinz, L Fehring, R Frese - Cells, 2022 - mdpi.com
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …
被引用次数：13 相关文章

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

C Prinz, L Fehring, R Frese - Cells, 2022 - pubmed.ncbi.nlm.nih.gov
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …
[HTML] nih.gov

[HTML][HTML] MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

C Prinz, L Fehring, R Frese - Cells, 2022 - ncbi.nlm.nih.gov
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions.

C Prinz, L Fehring, R Frese - Cells, 2022 - europepmc.org
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

C Prinz, L Fehring, R Frese - Cells, 2022 - search.proquest.com
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

C Prinz, L Fehring, R Frese - 2022 - agris.fao.org
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions.

C Prinz, L Fehring, R Frese - Cells (2073-4409), 2022 - search.ebscohost.com
The dysregulation of microRNAs has recently been associated with cancer development
and progression in pancreatic ductal adenocarcinoma (PDAC) and cystic pancreatic lesions …